NephroDI Therapeutics

Rare Disease Therapeutics · Biotechnology

Facts

as of Nov 17, 2026

About Us NephroDI Therapeutics is developing a novel AMPK activator as a first-in-class potential therapy for Nephrogenic Diabetes Insipidus (NDI). The genesis of this technology began with Drs.

Employees
1-10estimated range
Website
nephrodi.com
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Newsroom

top 10%Web presenceof 133.2M domains by links, Common Crawl
Sources: the outlets named on each headline, each story once